Effexor
Trovati 6 articoli
- Topamax linked to angle-closure glaucoma
- Topiramate ( Topamax ) is an antiepileptic indicated for either monotherapy or add-on therapy in adults and in children aged two years and over; and for the prophylaxis of migraine in adults. Topiramate has been rarely associated with the development of angle-closure glaucoma. To date, TGA ( T... (Leggi Articolo)
- Antidepressants: new warnings about suicidal thinking, behavior in young adults
- The FDA ( Food and Drug Administration ) proposed that makers of all antidepressant medications update the existing black box warning on their products' labeling to include warnings about increased risks of suicidal thinking and behavior, known as suicidality, in young adults ages 18 to 24 during... (Leggi Articolo)
- Depomedroxyprogesterone is effective treatment for hot flashes
- Researchers at Mayo Clinic, working with other North Central Cancer Treatment Group ( NCCTG ) investigators have found that a single dose of Depomedroxyprogesterone acetate ( MPA ) more effectively reduces hot flashes than does the antidepressant Venlafaxine ( Effexor / Efexor ). The study is... (Leggi Articolo)
- Pregnancy: newer antidepressants linked to persistent pulmonary hypertension in newborns
- The women who are taking antidepressants known as SSRI ( selective serotonin reuptake inhibitors ), and who are pregnant or intend to become pregnant, should discuss the situation with their doctor due to potential risks to the baby. The patients should not stop taking SSRI medication without ... (Leggi Articolo)
- Second-generation antidepressants very similar but have different side effects
- Many second-generation antidepressants, despite differences in drug classification and cost, offer patients essentially the same benefits with little variation in risks, University of North Carolina ( UNC ) at Chapel Hill researchers have found. Such antidepressants include selective serotonin... (Leggi Articolo)
- Breast cancer: polymorphisms in Tamoxifen metabolizing genes affect clinical outcome
- Researchers at University of Michigan and Mayo Clinic found that Tamoxifen may not be as effective for women who inherit a common genetic variation. The genetic variation affects the level of a crucial enzyme that activates Tamoxifen to fight breast cancer. The study, co-led by James Rae, a... (Leggi Articolo)
